Dosimetry in peptide receptor Radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and interpatient variability

被引：0
|
作者：
Wehrmann, C. [1 ]
Senftleben, S. [1 ]
Baum, R. P. [1 ]
机构：
[1] Zentralklin Bad Berka GmbH, Bad Berka, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S178 / S179
页数：2
相关论文
共 50 条
  • [21] Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide
    Heute, D. R.
    Dobrozemsky, G.
    Traub, T.
    Warwitz, B.
    von Guggenberg, E.
    Gabriel, M.
    Virgolini, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S202
  • [22] Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment
    Ataei-Nakhaei, Saeideh
    Aryana, Kamran
    Mostafavi, Sayyed Mostafa
    Kosari, Hadis Mohammadzadeh
    Esmatinia, Mohammad
    Aghaee, Atena
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (02):
  • [23] The technologist role in 177Lu dosimetry for PRRT (Peptide Receptor Radionuclide Therapy)
    Leoni, E.
    Filice, A.
    Palmieri, A.
    Ghiraldini, G.
    Fioroni, F.
    Grassi, E.
    Cola, S.
    Versari, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S850 - S851
  • [24] Comparison of Lu-177 DOTA-TATE sequential planar dosimetry scans with Ga-68 DOTA-TATE PET/CT images in patients with neuroendocrine tumours
    Sainz Esteban, A.
    Prasad, V.
    Carril Carril, J. M.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S231 - S232
  • [25] Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Side-effects and response to the radioisotope 90Y-DOTA-TATE or 90Y/177Lu DOTA-TATE therapy in patients with disseminated NET
    Sowa-Staszczak, Anna
    Kunikowska, Jolanta
    Krolicki, Leszek
    Mikolajczak, Renata
    Pawlak, Dariusz
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Trofimiuk, Malgorzata
    Pach, Dorota
    Hubalewska-Dydejczyk, Alicja
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [26] Individual dosimetry and monitoring response to treatment in tandem PRRT with [177Lu/90Y]-DOTA-TATE
    Kacperski, Krzysztof
    Budzynska, Anna
    Kubik, Agata
    Pastusiak, Patrycja
    Chalewska, Wioletta
    Lenda-Tracz, Wioletta
    Borkowska, Anna
    Walecka-Mazur, Agata
    Szczodry, Artur
    Braziewicz, Janusz
    Kolodziej, Maciej
    Kaminski, Grzegorz
    Dedecjus, Marek
    Dlugosinska, Joanna
    Januszkiewicz-Caulier, Joanna
    Hubalewska-Dydejczyk, Alicja
    Opalinska, Marta
    Kowalska, Aldona
    Mikolajczak, Renata
    POLISH JOURNAL OF MEDICAL PHYSICS AND ENGINEERING, 2024, 30 (04):
  • [27] PRRT using the radiolabelled somatostatin receptor antagonist Lu-177 DOTA-LM3: First Results of biodistribution and dosimetry in comparison with Lu-177 DOTATOC
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Far, M. Shahin
    Singh, A.
    Langbein, T.
    Lehmann, C.
    Fani, M.
    Maecke, H.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S589 - S589
  • [28] 177Lu-DOTA-TATE in Peptide Receptor Radionuclide Therapy: first year experience in Turkey
    Kabasakal, L.
    Demirci, E.
    Ocak, M.
    Decristoforo, C.
    Papilla, C.
    Araman, A.
    Uslu, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S428 - S428
  • [29] Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET
    Pach, Dorota
    Sowa-Staszczak, Anna
    Kunikowska, Jolanta
    Krolicki, Leszek
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Glowa, Boguslaw
    Mikolajczak, Renata
    Pawlak, Dariusz
    Jabrocka-Hybel, Agata
    Hubalewska-Dydejczyk, Alicja B.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) : 45 - 50
  • [30] Towards a quality assurance for dosimetry in peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE
    Marin, G.
    Vanderlinden, B.
    Wimana, Z.
    Guiot, T.
    Karfis, I.
    Flamen, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S159 - S160
12345